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SUmmAry – Aim: The aim of this study was to compare the incidence of postoperative hypo-
parathyroidism in two groups of patients who were treated for differentiated thyroid cancer. Methods: 
A retrospective analysis of 179 patients who were treated for differentiated thyroid cancer in our in-
stitution from January 2011 until december 2018 was performed. only patients initially treated with 
total thyroidectomy and those who did not have preoperatively confirmed central compartment and 
lateral neck lymph node metastases were included in this study. two main groups of patients were 
analysed. The patients who were treated with total thyroidectomy and elective central compartment 
lymph node dissection simultaneously were included in the first group. The patients who were treated 
only with total thyroidectomy were included in the second group. The rate of transitory and persistent 
postoperative hypoparathyroidism was compared between the two groups. Results: A total of 117 
patients (65.4%) underwent total thyroidectomy and elective central compartment lymph node dis-
section simultaneously (tt + CClnd group). The remaining 62 patients (34.6%) underwent total 
thyroidectomy only (tt group). A total of 22.6% patients in the tt group developed postoperative 
hypoparathyroidism compared with 25.6% in the tt + CClnd group. The rate of persistent hypo-
parathyroidism in the tt and tt + CClnd groups was 3.2% and 6.0%, respectively. The difference 
in the rate of transient and persistent postoperative hypoparathyroidism was not statistically signifi-
cant between the two groups. Within the tt + CClnd group, 82.9% of patients underwent ipsilat-
eral paratracheal lymph node dissection and 17.1% underwent bilateral paratracheal lymph node dis-
section. The rate of postoperative hypoparathyroidism was analysed in those two subgroups of patients 
and did not prove to be statistically significant. Discussion: While its impact on the local recurrence 
rate is still controversial, elective central compartment lymph node dissection could be a great tool for 
selection of patients who could profit from adjuvant radioiodine treatment. on the other hand, central 
compartment lymph node dissection could potentially increase the risk of hypoparathyroidism due to 
involuntary injury to parathyroid glands and/or their blood supply. our study did not find a statisti-
cally significant difference regarding postoperative hypoparathyroidism between patients who under-
went central compartment lymph node dissection compared with patients who underwent total thy-
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roidectomy only. our data are not in accordance with some of the previously published studies. Con-
clusion: our results demonstrated that elective central compartment lymph node dissection is a safe 
procedure and does not significantly increase the risk of postoperative hypoparathyroidism when it is 
performed simultaneously with total thyroidectomy.
key Words: differentiated thyroid cancer, total thyroidectomy, central compartment lymph node dissec­
tion, paratracheal dissection, postoperative hypoparathyroidism
Introduction
Thyroid cancer is the most common endocrine ma-
lignancy and its incidence rate has been increasing 
over the past several decades1,2. Papillary thyroid carci-
noma and follicular thyroid carcinoma both arise from 
the follicular cells and they are the most common types 
of thyroid cancer. together they are known as differen-
tiated thyroid cancer (dtC) and account for as much 
as 90% of all malignancies found in the thyroid gland3,4. 
While its incidence is high, the overall mortality for 
dtC remains very low. on the other hand, the risk of 
locoregional recurrence remains significantly high and 
metastases to regional lymph nodes are known to be 
an independent prognostic factor for it5-8. The other 
negative prognostic factors for locoregional recurrence 
after dtC treatment are tumor size, multifocality, and 
extrathyroidal extension7.
dtC shows a high tendency to metastasize to cen-
tral compartment lymph nodes (CCln) rather than 
to lateral cervical lymph nodes9. Anatomical boundar-
ies of the central neck compartment are the hyoid 
bone superiorly, the sternal notch inferiorly, and the 
medial borders of both carotid sheaths laterally. Be-
sides the thyroid gland and lymph nodes (centrally lo-
cated prelaryngeal and pretracheal and bilaterally lo-
cated paratracheal nodes), other structures found in 
this compartment are the esophagus, trachea, parathy-
roid glands, and recurrent laryngeal nerves10,11. The in-
ferior thyroid artery that supplies both superior and 
inferior parathyroid glands is also found in the para-
tracheal space12. 
The rate of metastatic CCln involvement recog-
nized on preoperative high-resolution ultrasound is 
not higher than 30 %13-15. on the other hand, the rate 
of occult CCln metastases detected on pathological 
specimens after elective central compartment lymph 
node dissection (CClnd) varies from 20 to up to 
60%16-18.
There are still controversies about adequate dtC 
treatment regarding both the operation of the primary 
tumor and management of clinically negative CCln. 
The treatment strategy varies from thyroid lobectomy 
as a definitive procedure to total thyroidectomy (tt) 
plus elective CClnd. The main complication of tt is 
postoperative hypoparathyroidism, and synchronous 
elective CClnd can even increase its incidence.
The aim of this study was to analyze the impact of 
elective CClnd on the incidence of postoperative hy-
poparathyroidism in two group of patients who were 
treated for dtC.
Methods
We performed a retrospective analysis of 179 pa-
tients who were treated for dtC in our institution 
from January 2011 until december 2018. only pa-
tients initially treated with tt were included in this 
study. All patients treated with less than tt and those 
treated in two-stage completion thyroidectomy were 
excluded from analysis. Patients with synchronous lat-
eral neck metastases and patients with associated hy-
per- or hypoparathyroidism were excluded from the 
study as well.
All patients underwent neck ultrasound examina-
tion with special focus on the thyroid gland, CCln, 
and lateral neck lymph nodes as a standardized preop-
erative protocol. All suspicious lymph nodes were fur-
ther analysed with fine needle aspiration cytology 
(fnAC). none of the patients included in this study 
had CCln or lateral neck metastases confirmed on 
preoperative neck ultrasound and/or fnAC.
two main groups of patients were created and ana-
lysed separately. All the patients who were initially 
treated only with tt were placed in the first group 
(tt group). The patients who underwent elective 
CClnd simultaneously with tt were placed in the 
second group. (tt + CClnd group). The decision on 
whether or not to perform an elective CClnd simul-
taneously with tt was left to the surgeon’s preference.
The rate of transitory and persistent postoperative 
hypoparathyroidism was compared between the two 
groups.
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A blood sample for Pth determination was col-
lected in a 5 ml vacuette Z serum separator clot acti-
vator tube (Greiner Bio-one Gmbh, 4550 krems-
münster, Austria). After centrifugation of the samples 
at 3500 rpm/10 minutes we measured Pth concen-
tration by electrochemiluminescence immunoassay on 
the Cobas e411 analyzer (hitachi, tokyo, Japan) using 
the original manufacturer’s reagents, calibrators, and 
controls from the roche company (roche diagnostics 
Gmbh, d-68298 mannheim, Germany). The labora-
tory continuously implements two independent sys-
tems for assessment of external quality control: Cro-
Qalm (Croatian Society of medical Biochemistry and 
laboratory medicine) and labquality (helsinki, fin-
land).
transitory hypoparathyroidism was considered 
when the serum Pth level was below the reference 
range and patients received vitamin d or/and calcium 
supplementation in the period after the discharge from 
the hospital up to one year after surgery. All the pa-
tients dependent on supplementation therapy for more 
than one year after surgery were diagnosed with per-
manent hypoparathyroidism.
The chi square test was used to compare the differ-
ences between the groups, except in small observed 
frequencies when the yates corrected chi-square test 
was used. Statistical significance was set at p<0.05.
Results
out of 179 patients included in this study, there 
were 142 women (79%) and 37 men (21%) with a 
mean age of 51 (range 20-86 years of age) (table 1).
A total of 117 patients (65.4%) underwent simul-
taneous tt and elective CClnd (tt + CClnd 
group). The remaining 62 patients (34.6%) only un-
derwent tt (tt group).
out of 62 patients within the tt group, 14 (22.6%) 
developed postoperative hypoparathyroidism. Within 
the tt + CClnd group the rate of postoperative hy-
poparathyroidism was slightly higher (30 of 117 pa-
tients or 25.6%), but there was no significant statistical 
difference between the two groups (χ2=0.205; df=2; 
p= 0.651).
Persistent hypoparathyroidism after at least one 
year of clinical follow-up was confirmed in 2 patients 
in the tt group (3.2%) and 7 patients in the tt + 
CClnd group (6.0%). The difference was not statisti-
cally significant (yates χ2 = 0.197; df=2; p= 0.957). 
Three patients in the tt group (4.8%) and 3 patients 
within tt + CClnd group (2.6%) were lost to fol-
low-up (figure 1).
Within the tt + CClnd group, 97 patients 
(82.9%) underwent ipsilateral paratracheal lymph 
node dissection and 20 patients (17.1%) underwent 
bilateral paratracheal lymph node dissection. Pretra-
cheal lymph nodes were removed in all the patients.
The incidence of postoperative hypoparathyroid-
ism was 24.7 % and 30.0% in the ipsilateral and bilat-
Table 1. Characteristics of study patients




Age, mean (range) 51 (20-86)
operation
total thyroidectomy 62 (34.6%)
total thyroidectomy + central 
compartment lymph node dissection 117 (65.4%)
type of central compartment lymph 
node dissection
Pretracheal + ipsilateral paratracheal 97 (82.9%)
Pretracheal + bilateral paratracheal 20 (17.1%)
Figure 1. The rate of transitory and persistent 
hypoparathyroidism between the TT and TT + CCLNd 
groups.
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eral dissection groups, respectively. Although expected, 
the difference was still not found to be significant (χ2 
=0.24; df=2; p=0.624) (figure 2).
Within the tt + CClnd group, 45 patients 
(38.5%) were diagnosed with metastatic lymph nodes 
on the final pathological report (positive subgroup). in 
the remaining 72 patients (61.5%), no positive lymph 
nodes were found in the pathological specimen (nega-
tive subgroup).
The incidence of postoperative hypoparathyroid-
ism in the positive and negative subgroup was 31.1% 
and 22.2% respectively, and the difference was also not 
shown to be statistically significant (χ2 =1.148; df=2; 
p=0.284).
Discussion
The incidence of dtC has been increasing over the 
past decades. despite its generally excellent prognosis, 
dtC may also present with the more aggressive tumor 
features, including multifocality, local nodal metasta-
sis, and extrathyroidal spread. Consequently, there is 
still an ongoing debate about the appropriate surgical 
management for dtC. Some authors are in favor of 
unilateral lobectomy as an adequate surgical treatment 
for all tumors up to 4 centimeters in diameter and 
without any adverse pathological features (multifocal-
ity, extrathyroidal spread, lateral neck metastases). The 
majority of other authors consider only tt to be the 
optimal treatment strategy for all tumors greater than 
1 centimeter19-21. Even microcarcinomas are treated 
with tt by some surgeons20. Similarly, management 
of regional CCln remains controversial. metastatic 
CCln involvement on preoperative clinical or imag-
ing assessment is a well-established indication for 
therapeutic dissection10. on the other hand, validity of 
an elective CCln dissection is still the subject of an 
open discussion. kutler et al. documented that CCln 
dissection is a safe procedure and may decrease the 
need for further reoperations because of the local re-
currence23. in direct contrast, a meta-analysis by Shan 
et al. found no benefit in performing tt with CClnd 
versus tt alone with regard to locoregional recur-
rence. They instead demonstrated a higher risk of post-
operative complications9.
A decision to perform routine CCln dissection 
may have implications on the postoperative treatment. 
A study by Bonnet et al. found that precise staging of 
CCln led to a change in tnm classification in 30.5 
% of patients and that it can play a role in further deci-
sions to treat these patients with radioactive iodine24.
Postoperative hypoparathyroidism and hypocalce-
mia are the most common complications after tt and 
often result in prolongation the hospital stay and de-
creased quality of life. The incidence of transitory hy-
poparathyroidism after tt is described to be within a 
wide range from 6.9-46.0% 25,26. The incidence of per-
sistent hypoparathyroidism is reported to be 0-9%27.
CClnd potentially increases the risk of hypopara-
thyroidism due to involuntary injury of parathyroid 
glands and/or the inferior thyroid artery that runs 
through paratracheal space. There are numerous re-
ports showing that tt with elective CClnd is associ-
ated with a higher rate of postoperative hypoparathy-
roidism9,28,29.
in contrast, we could not find any statistically sig-
nificant difference between the two analyzed groups of 
patients in our study. The incidence of postoperative 
transitory and persistent hypoparathyroidism did not 
differ statistically in the group of patients who under-
went CClnd compared with the group of patients 
who underwent tt only. Surprisingly, the incidence 
was not higher even in the subgroup of patients who 
underwent bilateral paratracheal dissection compared 
with ipsilateral or in the subgroup of patients with 
confirmed metastatic lymph nodes.
Figure 2. The rate of postoperative hypoparathyroidism 
compared between group of patients who underwent 
ipsilateral and bilateral paratracheal dissection.
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Some of the above data are in contradiction with 
many of the previous studies9,30,31.
Based on our data, we think that CClnd is a safe 
procedure in hands of a well-trained surgeon and that 
it does not significantly increase the incidence of post-
operative hypoparathyroidism. While its significance 
on the local recurrence rate is still the subject of dis-
cussion, elective CClnd could be a great tool for se-
lection of patients with occult metastatic lymph nodes 
who are candidates for further radioiodine ablation. 
Although our data indicate otherwise, we would still 
advocate unilateral paratracheal dissection rather than 
bilateral, in order to reduce the risk of postoperative 
hypoparathyroidism. Bilateral paratracheal dissection 
should only be considered in cases where there are 
multifocal tumors localized in both lobes or centrally 
localized isthmic tumors, and when suspicious lymph 
nodes are found bilaterally.
from our perspective, the main downside of our 
study is the randomization of patients into two main 
groups. rather than blindly, their randomization was 
based on the surgeon’s preference in performing elec-
tive CClnd, which could potentially lead to bias.
Conclusion
When performed routinely, CClnd is a safe pro-
cedure that does not significantly increase the risk of 
postoperative hypoparathyroidism. furthermore, it 
can select patients for postoperative radioiodine treat-
ment. We strongly advocate referral of all patients with 
thyroid cancer to highly-volume centers where 
CClnd can be performed safely and effectively.
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Sažetak
ElEktivnA diSEkCiJA rEGiJE vi nE PovEĆAvA riZik  
PoStoPErAtivnoG hiPoPArAtirEoidiZmA  
kod BolESnikA liJEČEnih ZBoG doBro difErEnCirAnoG kArCinomA ŠtitnJAČE
B. Stubljar, M. Pastorčić Grgić, Lj. Mayer, P. Perše i T. Tomičević
Cilj: Cilj rada je usporediti incidenciju postoperativnog hipoparatireoidizma između dvije skupine bolesnika liječenih 
zbog dobro diferenciranog karcinoma štitnjače. Metode: retrospektivno smo analizirali 179 bolesnika koji su u našoj usta-
novi liječeni zbog dobro diferenciranog karicnoma štitnjače u periodu od siječnja 2011 do prosinca 2018. U studiju su bili 
uključeni samo bolesnici kod kojih je inicijalno učinjena totalna tiroidektomija te oni koji na osnovu preoperativne obrade 
nisu imali potvrđene metastaze na lateralnom vratu i u regiji vi. Analizirane su dvije skupine bolesnika. U prvu skupinu su 
uključeni bolesnici kod kojih je u istom aktu učinjena totalna tireoidektomija i disekcija regije vi. Svi ostali bolesnici kod 
kojih je učinjena samo totalna tireoidektomija uključeni su u drugu skupinu. Stopa tranzitornog i trajnog hipoparatireoidiz-
ma je uspoređivana između dvije skupine. Rezultati: kod ukupno 117 bolesnika (65,4%) učinjena je disekcija regije vi 
istodobno s totalnom tireoidektomijom. (tt + CClnd skupina). kod preostalih 62 bolesnika (34,6%) učinjena je samo 
totalna tireoidektomija. (tt skupina). Ukupno 22,6% bolesnika iz tt skupine je razvilo postoperativni hipoparatireoidizam 
usporedno s 25,6% bolesnika iz tt + CClnd skupine. Stope trajnog hipoparatireoidizma u tt i tt + CClnd skupinama 
su iznosile 3,2 i 6 %. Stopa tranzitornog kao i trajnog postoperativnog hipoparatireoidizma nije bila statistički značajna iz-
među dvije skupine. Unutar tt + CClnd skupine, kod 82,9% bolesnika je učinjena disekcija ipsilateralnih paratrahealnih 
limfnih čvorova, za razliku od 17,1% bolesnika kod kojih je učinjena disekcija bilateralnih paratrahealnih čvorova. Stopa 
postoperativnog hipoparatireoidizma je analizirana u dvjema podskupinama i nije se pokazala statistički značajnom. Raspra-
va: iako je utjecaj elektivne disekcije regije vi na lokoregionalno recidiviranje i dalje kontroverzan, ona može biti odličan alat 
za probir bolesnika koji mogu imati korist od adjuvantne radiojodne ablacije. S druge strane, disekcija regije vi potencijalno 
može povećati rizik hipoparatireoidizma zbog nenamjerne ozljede doštitnih žlijezda ili/i njihove krvne opskrbe. naša studi-
ja nije pokazala statistički značajnu razliku u stopi postoperativnog hipoparatireoidizma između skupine bolesnika kod kojih 
je učinjena disekcija regije vi u usporedbi sa skupinom bolesnika kod kojih je učinjena samo totalna tireoidektomija. naši 
podaci su u proturiječju s nekim ranije publiciranim studijama. Zaključak: naši rezultati su pokazali da je elektivna disekcija 
regije vi sigurni postupak i značajno ne povećava rizik postoperativnog hipoparatireoidizma kada se izvodi istodobno s to-
talnom tireoidektmijom.
ključne riječi: dobro diferencirani karcinom štitnjače, totalna tiroidektomija, disekcija regije VI, paratrahealna disekcija, post­
operativni hipoparatireoidizam
